A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TN / tetranectin

[Related PubMed/MEDLINE]
Total Number of Papers: 44
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TN  (>> Co-occurring Abbreviation)
Long Form:   tetranectin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Adipogenic function of mouse tetranectin and identification of its functional domain. PA, PLG, Pln, rmTNs
2018 The relationship between the expression of TN and the efficiency of posterior spinal V osteotomy in patients with traumatic kyphosis. ---
2016 Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion Protein. apoA-I, HDL
2015 Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease. IHC
2015 Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study. BOTs, CSS, OC, OS
2014 Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation. APOL1, apoM, ELISA, IgL, LDH
2014 Tetranectin knockout mice develop features of Parkinson disease. LBs, PD, SNc, WT
2010 Alterations in biomarkers of endothelial function following on-pump coronary artery revascularization. ACE, CPB, PD, SIRS, sPs, vWF
2010 Serum tetranectin as a preoperative indicator for postoperative complications in Danish ovarian cancer patients. OC
10  2010 Serum tetranectin is a significant prognostic marker in ovarian cancer patients. OvCa
11  2010 Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy. CSF
12  2009 Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors. BOT, OC, RAI
13  2009 Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. CSF, DBP, IGKV1-5, SOD1, TLE
14  2007 Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer. TCC
15  2006 Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link. HS, LPO, T1DM
16  2006 Tetranectin in cerebrospinal fluid of patients with multiple sclerosis. CSF, MS, Qalb
17  2005 In the search of potential human islet stem cells: is tetranectin showing us the way? ---
18  2005 Tetranectin in cerebrospinal fluid: biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF. ---
19  2004 Aberrant tetranectin expression in human breast carcinomas as a predictor of survival. ---
20  2004 The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients. CA125, OC, suPAR, uPAR
21  2002 Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA. CEA, PAI-1, uPAR
22  2002 The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer. ---
23  2001 Tetranectin-like protein in vertebrate serum: a comparative immunochemical analysis. ---
24  2000 Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass. OC
25  2000 Serum tetranectin and CA125 in endometrial adenocarcinoma. ---
26  2000 The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer. OC
27  1999 Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. B-CLL, BMI, cICAM-1, HS, IL-10, LDH
28  1998 Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis. IL-8, OA, RA, SF, SSA
29  1998 Human tetranectin: methodological and clinical studies. mAbs
30  1998 Structure of the C-type lectin carbohydrate recognition domain of human tetranectin. CRD
31  1998 Tetranectin levels in patients with acute myocardial infarction and their alterations during thrombolytic treatment. alpha 2-PI, AMI, DD, HS
32  1997 Human plasminogen binding protein tetranectin: crystallization and preliminary X-ray analysis of the C-type lectin CRD and the full-length protein. ---
33  1997 Monoclonal antibodies against human tetranectin, epitope characterization and use in immunohistochemistry. mAbs
34  1997 Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis. RA, tPA
35  1996 Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancer. ---
36  1995 Cloning of a cDNA encoding murine tetranectin. aa
37  1995 Ovarian carcinoma serum markers and ovarian steroid activity--is there a link in ovarian cancer? A correlation of inhibin, tetranectin and CA-125 to ovarian activity and the gonadotropin levels. ---
38  1993 Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patients. RH
39  1993 The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. ---
40  1992 A comparison of the inhibitory effects of immunosuppressive agents cyclosporine, tetranactin, and didemnin B on human T cell responses in vitro. APC/AC, DB
41  1992 Changes in plasma tetranectin following hip surgery with or without thrombotic complications. DVT
42  1991 Differences in tetranectin immunoreactivity between benign and malignant breast tissue. FN
43  1989 Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. ---
44  1987 Immunosuppressive effects of polynactins (tetranactin, trinactin and dinactin) on experimental autoimmune uveoretinitis in rats. EAU, PN